The aim of the study was to investigate the effect of chitosan on the dissolution of ketoprofen incorporated into this polymer carrier. The study investigated ketoprofen in physical mixtures at the drug to polymer ratios of 1:9, 3:7, and 5:5 
Introduction
Solubility and permeability are the fundamental parameters controlling the rate and extent of drug absorption. Amidon and co-workers devised a Biopharmaceutical Classification System (BCS) that categorised drugs into four classes according to their solubility and permeability properties. The objective of the BCS is to predict the in vivo pharmacokinetic performance of drug products from measurements of permeability and solubility [1, 2] .
Ketoprofen is also known as 2-(3-benzoyl phenyl) propionic acid. It has anti-inflammatory, analgesic and antipyretic effects, and is used in a wide variety of acute and chronic inflammatory diseases and in the treatment of rheumatoid arthritis.
Ketoprofen belongs to class II of the BCS, which means that its low water solubility is the limiting step for absorption and bioavailability. Several methods have been used to improve the oral bioavailability of poorly soluble drugs as an example solid dispersion technique with water soluble carriers. The increase in the dissolution rate of poorly water soluble drugs from solid dispersions can be attributed to one or a combination of different factors [3, 4] .
Solid dispersion is one of these methods, and involves the dispersion of drugs in an inert carrier in the solid state prepared by melting, solvent or solvent-melting method.
Solid dispersions with the use of polymers, especially chitosan, as a carrier, play an exceptional role. Chitosan, dispersing in water environments, causes a significant increase in the contact area of the drug with solution, increases its hydrophilic properties and may affect its crystalline structure. All of these factors lead to increased solubility of the drug [5, 6] .
Thus, a study was undertaken to investigate the effect of chitosan on the solubility of ketoprofen incorporated into this polymer carrier. Studies were carried out for different viscosity and average molecular weights of chitosan.
Demonstration of the effect of chitosan on the average molecular weight in various formulations or with various methods of preparation of the solid dispersions on the dissolution of ketoprofen may enable the development of new preparations of this drug with increased solubility.
Materials and methods

Materials
The study was performed with the use of ketoprofen (Ketoprofen p.a. min. 99%, Zhejiang Chemicals) incorporated into natural, highly purified chitosan sample S with 92% deacetylation and viscosity average molecular weight M η = 1087 kDa, intrinsic viscosity η = 0.7437 [dm 3 
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(Chitosan Huasu p.a., Chitin, France), sodium lauryl sulphate p.a., PPH "Stanlab", Poland, Aqua purification, acc. to FP IX.
Methods
Examination of pure ketoprofen and its physical mixtures dissolution rate
Evaluation of dissolution was performed in a dissolution apparatus according to FP IX, which describes the investigation of active substance solubility rate from solid drug forms [7] . The examination was performed in a VanKel VK 7025 dissolution apparatus, to which a Varian Inc. fraction collector was attached. Here, 1000 ml of 0.1 M hydrochloric acid at pH 1.5 was used as a release medium. Solubility was evaluated after compressing 100 mg of samples, which were placed in each of the six chambers of the apparatus at 37 ± 0.5 °C, with velocity of 90 rotations per minute. The trial was continued for 1 hour, with 5 ml samples collected at 10 time intervals, i.e. after 5, 10, 15, 20, 25, 30, 35, 40, 50 and 60 minutes. Collected samples were filtered using filters with a pore size of 10 µm.
The collected samples were diluted and next their content was evaluated with the use of a JASCO V650 spectrophotometer with a 1 cm cuvette at a wavelength of λ = 260 nm.
The drug concentration in samples and an average percentage of dissolved ketoprofen were calculated using a linear regression equation for ketoprofen, y = 0.06028 x + 0.0321. Quantitative drug-to-polymer ratios in which the solid dispersion had the most beneficial properties improving drug solubility were determined.
Technology for the preparation of investigated formulations
Preparation of samples for investigation of ketoprofen dissolution
The dissolution of ketoprofen was investigated immediately after compressing the powders in a Specac hydraulic press. The 100 mg samples weighed on a Mettler balance were pressed on a punch die with a diameter of 13 mm. The pure drug and physical mixtures were pressed at a pressure of 5 ton for 10 sec.
Preparation of ketoprofen and polymer physical mixtures.
Physical mixtures were prepared by grinding adequate amounts of ketoprofen in an agate mortar for 10 minutes with chitosan with an average molecular weight of: M η = 1087 kDa, M η = 839 kDa, M η = 407 kDa at drug-to-polymer weight ratios of 1:9, 3:7 and 5:5 weighed on a Sartorius analytical balance. The prepared physical mixtures were passed through a sieve with 315 µm holes, and next placed in glass bottles sealed with cork and stored in an exicator over silica gel. Every sample was prepared in 1 g amount ( Table 1) .
Statistical analysis
Statistical analysis was performed for the maximum percentage values of ketoprofen solubility (in 60 minutes) from dispersions containing chitosan. The effects of chitosan as well as the effect of the dispersion preparation method on the drug solubility were analysed. In order to check the normality of the distribution of variables, the following tests were performed: Kolmogorov-Smirnov, Lilliefors, and the Shapiro-Wilk tests. Next, the variance homogeneity B. Grimling, M. Szcześniak, J. Meler, J. Pluta was checked by means of the Brown-Forsythe's test at a significance level p < 0.05; ANOVA variance analysis was also performed. Table 2 presents the solubility of pure ketoprofen without the presence of chitosan prepared according to p. 2.2.1. The solubility findings of pure ketoprofen in 0.1 n solution HCl were used as a reference to compare the solubility of the drug incorporated into chitosan.
Results and discussion
The drug solubility was found to increase gradually, accounting for 0.1% to 3.05% of the investigated dose. Tables 2 -5 and the plotted dissolution curves shown in Figure 1 revealed that the addition of chitosan had a beneficial effect on the ketoprofen dissolution profile in the investigated physical mixtures.
Analysis of the data included in
The results of the study demonstrated that all of the investigated physical dispersions of ketoprofen with chitosan increased the solubility of this drug. 
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The solubility findings of pure ketoprofen in 0.1 n HCl were used as reference to compare the solubility of the drug incorporated into chitosan. The drug dissolution was found to increase gradually and ranged from 0.1% at 5 min to 3.05% at 60 min for the investigated dose.
The presence of chitosan significantly increased the solubility of ketoprofen, which increased with duration of the trial and with increasing percentage of polymer in the formulations.
The dissolution of ketoprofen, amounting to 71%, was observed after 5 minutes from physical mixtures containing the drug-to-polymer weight ratio 1:9 in the presence of chi- tosan S. In dispersions containing 30% of the drug and polymer, the solubility of ketoprofen was observed to reach a level of 48% after 5 minutes. The lowest solubility was observed in dispersions in which the drug-to-polymer weight ratio was 5:5, in which case the drug solubility was slightly above 32%.
The highest dissolution of ketoprofen, amounting to 99%, was observed after 60 minutes from physical mixtures containing the different drug-to-polymer weight ratios in the presence of chitosan B.
Comparing data from Tables 3 and Figure 1 , we can see a significant increase in the drug solubility, which increased almost 33 times in the presence of chitosan in comparison to the solubility of pure drug.
When the course of ketoprofen solubility curves in the presence of chitosan is observed, it becomes apparent that they are situated in the field above the ketoprofen solubility curve without polymer. The solubility curve for drug mixed with chitosan S at a ratio of 1:9 assumes the highest position in the field; also, the inclination angle of the straight line to time axis is significant, and the drug solubility in relation to time ranges from 71.09% to 98.45%, i.e. it increases with time.
The solubility line of pure ketoprofen is characterised by a low inclination angle to the time axis, and the drug solubility in time increases slightly from 0.1% to 3.05%. The increased solubility of ketoprofen in physical mixtures with chitosan may be explained by numerous factors; the decreased size of the molecules may be the first. Chitosan, when dispersed in water, may cause molecular dispersion of the drug by increasing the surface of the drug solubility [8] .
Comparison of data from Tables 2 -5 and Figure 1 demonstrates a significant increase in drug solubility, which in the presence of chitosan -Mη = 1087 kDa (sample MFS) in 
dispersions, was almost 33 times higher in relation to the amount of added polymer in comparison to the solubility of pure drug. It was noticed that the dissolution rate of ketoprofen from the dispersions 1:9 in the presence of chitosan -Mη = 839 kDa (sample MFA) and Mη = 407 kDa (sample MFB) at 5 minutes was obviously higher than that from the dispersions with chitosan -Mη = 1087 kDa.
The enhancement of drug dissolution rate is 33-fold for the weight ratio 1:9 solid dispersion ketoprofen in chitosan -Mη = 839 kDa and chitosan -Mη = 407 kDa.
In dispersions containing 10% of the drug and 90% chitosan with an average molecular weight of approximately 839 kDa, the solubility of ketoprofen was dependent on time from 75.5 to 98.5%. The highest solubility was observed in dispersions in which the drug was incorporated in chitosan with an average molecular weight of approximately 407 kDa, in which case the drug solubility was dependent on time from 81.95 to 99.45%. The results demonstrated higher drug dissolution of the physical mixtures containing chitosan sample B than that of chitosan sample A and sample S.
Chitosan in dispersions may prevent the agglomeration of ketoprofen molecules and increase the wettability of drug molecules, thus intensifying drug solubility. The above findings were supported by statistical analysis of the investigated samples.
Normality tests performed for the percentage amount of dissolved ketoprofen after 60 minutes in relation to the drug-to-polymer weight ratio revealed the normal distribution of data. Variance analysis demonstrated statistically significant differences in the findings in relation to the applied composition of physical mixtures. Values p<0.05 were assumed to be statistically significant. 
